A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 538,200 shares of PTCT stock, worth $24.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
538,200
Previous 818,100 34.21%
Holding current value
$24.3 Million
Previous $25 Million 20.19%
% of portfolio
0.03%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$30.39 - $37.66 $8.51 Million - $10.5 Million
-279,900 Reduced 34.21%
538,200 $20 Million
Q2 2024

Aug 09, 2024

BUY
$24.69 - $40.12 $1.4 Million - $2.27 Million
56,700 Added 7.45%
818,100 $25 Million
Q1 2024

May 13, 2024

BUY
$24.15 - $31.95 $3.34 Million - $4.43 Million
138,500 Added 22.23%
761,400 $22.1 Million
Q4 2023

Feb 13, 2024

BUY
$18.07 - $29.37 $7.02 Million - $11.4 Million
388,300 Added 165.52%
622,900 $17.2 Million
Q3 2023

Nov 14, 2023

BUY
$22.41 - $41.99 $5.26 Million - $9.85 Million
234,600 New
234,600 $5.26 Million
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $234,360 - $301,560
5,600 New
5,600 $281,000
Q1 2022

May 13, 2022

SELL
$33.33 - $44.6 $733,260 - $981,200
-22,000 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$35.36 - $41.86 $2.11 Million - $2.49 Million
-59,600 Reduced 73.04%
22,000 $876,000
Q3 2021

Nov 12, 2021

SELL
$37.01 - $44.74 $4.57 Million - $5.52 Million
-123,410 Reduced 60.2%
81,600 $3.04 Million
Q2 2021

Aug 13, 2021

BUY
$37.95 - $49.37 $524,089 - $681,799
13,810 Added 7.22%
205,010 $8.67 Million
Q1 2021

May 13, 2021

BUY
$46.8 - $68.92 $8.95 Million - $13.2 Million
191,200 New
191,200 $9.05 Million
Q3 2020

Nov 13, 2020

SELL
$45.41 - $57.07 $236,131 - $296,764
-5,200 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$42.56 - $54.98 $15.9 Million - $20.6 Million
-374,200 Reduced 98.63%
5,200 $264,000
Q1 2020

May 14, 2020

BUY
$32.37 - $59.36 $2.12 Million - $3.89 Million
65,500 Added 20.87%
379,400 $16.9 Million
Q4 2019

Feb 13, 2020

BUY
$32.22 - $50.07 $5.92 Million - $9.19 Million
183,600 Added 140.91%
313,900 $15.1 Million
Q3 2019

Nov 13, 2019

SELL
$33.82 - $48.17 $8.07 Million - $11.5 Million
-238,760 Reduced 64.69%
130,300 $4.41 Million
Q2 2019

Aug 12, 2019

SELL
$35.42 - $45.0 $19.1 Million - $24.2 Million
-538,240 Reduced 59.32%
369,060 $16.6 Million
Q1 2019

May 14, 2019

SELL
$28.09 - $39.49 $3.24 Million - $4.56 Million
-115,400 Reduced 11.28%
907,300 $34.2 Million
Q4 2018

Feb 13, 2019

BUY
$29.83 - $46.51 $30.5 Million - $47.6 Million
1,022,700 New
1,022,700 $35.1 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.24B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.